Paloma Partners’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-16,726
| Closed | -$373K | – | 1372 |
|
|
2021
Q4 | $373K | Buy |
+16,726
| New | +$373K | 0.01% | 1026 |
|
|
2021
Q3 | – | Sell |
-11,764
| Closed | -$458K | – | 1001 |
|
|
2021
Q2 | $458K | Buy |
11,764
+208
| +2% | +$8.1K | 0.01% | 841 |
|
|
2021
Q1 | $333K | Buy |
+11,556
| New | +$333K | 0.01% | 1223 |
|
|
2020
Q1 | – | Sell |
-36,249
| Closed | -$1.37M | – | 1219 |
|
|
2019
Q4 | $1.37M | Buy |
+36,249
| New | +$1.37M | 0.02% | 628 |
|
|
2019
Q3 | – | Sell |
-18,900
| Closed | -$988K | – | 1630 |
|
|
2019
Q2 | $988K | Sell |
18,900
-57
| -0.3% | -$2.98K | 0.02% | 547 |
|
|
2019
Q1 | $1.31M | Buy |
+18,957
| New | +$1.31M | 0.03% | 416 |
|
|
2018
Q1 | – | Sell |
-52,400
| Closed | -$5.74M | – | 1438 |
|
|
2017
Q4 | $5.74M | Buy |
52,400
+50,271
| +2,361% | +$5.51M | 0.08% | 105 |
|
|
2017
Q3 | $210K | Sell |
2,129
-7,891
| -79% | -$778K | ﹤0.01% | 1375 |
|
|
2017
Q2 | $1.02M | Buy |
10,020
+718
| +8% | +$72.7K | 0.01% | 770 |
|
|
2017
Q1 | $1.08M | Buy |
+9,302
| New | +$1.08M | 0.01% | 780 |
|
|
2016
Q4 | – | Sell |
-1,825
| Closed | -$205K | – | 1521 |
|
|
2016
Q3 | $205K | Buy |
+1,825
| New | +$205K | ﹤0.01% | 1275 |
|
|
2016
Q2 | – | Sell |
-3,875
| Closed | -$436K | – | 1725 |
|
|
2016
Q1 | $436K | Buy |
3,875
+1,672
| +76% | +$188K | 0.01% | 1000 |
|
|
2015
Q4 | $240K | Buy |
+2,203
| New | +$240K | 0.01% | 1135 |
|
|
2015
Q3 | – | Sell |
-17,568
| Closed | -$2M | – | 1317 |
|
|
2015
Q2 | $2M | Buy |
17,568
+12,268
| +231% | +$1.4M | 0.04% | 312 |
|
|
2015
Q1 | $554K | Buy |
+5,300
| New | +$554K | 0.02% | 639 |
|
|
2014
Q1 | – | Sell |
-3,621
| Closed | -$691K | – | 673 |
|
|
2013
Q4 | $691K | Buy |
+3,621
| New | +$691K | 0.03% | 488 |
|